Wednesday - April 29, 2026

Engineered Nucleases That Target Human and Canine Factor VIII Genes as a Treatment for Hemophilia A

2026-04-07

ALEXANDRIA, Virginia, April 7 -- PRECISION BIOSCIENCES, INC., Durham, North Carolina has been assigned a patent (No. US 12595470 B2, initially filed Feb. 23, 2024) developed by five inventors Armin Hekele, Cary, North Carolina; Clayton Beard, Durham, North Carolina; Derek Jantz, Durham, North Carolina; James Jefferson Smith, Morrisville, North Carolina; and Victor Bartsevich, Durham, North Carolina, for "Engineered nucleases that target human and canine factor VIII genes as a treatment for hemo . . .

Information Request Form

Name:
Category that best fits the type of business or agency you are affiliated with:	Government Newspaper / Media Business Public Policy Individual / Student Educators
Company Name:
Email:
Phone:
State:

I'd like to have a copy of this article mailed to me.

To also receive a free sample of other Targeted News products check the appropriate boxes below.
Golf Handicap site (FairwayFiles.com)
Products marked with ** can be customized by keywords or areas of interest. If you select them please specify your keywords in the box below:

If we need to contact you please specify your preferred contact method. Have a representative contact me by phone
Have a representative contact me via email

Additonal questions or comments:

Click here for more information or a free trial

Existing Customer Login

Engineered Nucleases That Target Human and Canine Factor VIII Genes as a Treatment for Hemophilia A

Information Request Form

Copyright Targeted News Service 2026